SEC Form 4 · accession 0002028640-26-000008
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jan Malcolm
Director
Period of report
Jul 22, 2026
Accepted (ET)
Jul 23, 2026 · 4:43 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 450 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2,F1,F3,F4 | $0.00 | Jul 22, 2026 | A | 380 | A | Jun 25, 2027 | — | Common Stock | 380 | 380 | D |
| Stock OptionF2,F3 | $527.07 | Jul 22, 2026 | A | 1,190 | A | Jun 25, 2027 | Jul 22, 2033 | Common Stock | 1,190 | 3,570 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- F2Annual non-employee director award.
- F3Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
- F4Not applicable as restricted stock units do not have an expiration date.